Discontinued — last reported Q3 '21
Business Segments · Restructuring Charges
Lab Corp Diagnostics — Restructuring Charges
Labcorp Holdings Lab Corp Diagnostics — Restructuring Charges decreased by 31.0% to $2.00M in Q3 2021 compared to the prior quarter. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementSegment
CategoryEfficiency
SignalLower is better
VolatilityVolatile
First reportedQ1 2015
Last reportedQ3 2021
Rolls up toRestructuring Charges
How to read this metric
Higher charges reflect aggressive operational changes, which may lead to future margin expansion if the initiatives are successful.
Detailed definition
This captures the gross expenses recognized in the income statement related to the Diagnostics segment's restructuring i...
Peer comparison
Standard operating expense line item for companies undergoing significant organizational change; comparable to restructuring expenses at other large-scale diagnostic labs.
Metric ID:
lh_segment_lab_corp_diagnostics_restructuring_chargesHistorical Data
2 periods
| Q2 '21 | Q3 '21 | |
|---|---|---|
| Value | $2.90M | $2.00M |
| QoQ Change | — | -31.0% |
Range$2.00M – $2.90M
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Labcorp Holdings's lab corp diagnostics — restructuring charges?
- Labcorp Holdings (LH) reported lab corp diagnostics — restructuring charges of $2.00M in Q3 2021.
- What does lab corp diagnostics — restructuring charges mean?
- The total gross expenses incurred during a specific period for restructuring business operations.